Cases with FAB M2 displayed the most heterogeneous CD105 expression profile (Fig. 2D), and a significant lower proportion of CD105 positive AML blasts was observed in patients with FAB M3 (SFI 1.06; 2.7%) compared to the other FAB types (Fig. 2E). Here, ENG is linked to acute myeloid leukemia.